Current Studies | UnityPoint Health - Des Moines

UnityPoint Clinic Urgent Care - Altoona

07 Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ingersoll

01 Patients
Waiting Now

Urgent Care - Ankeny

02 Patients
Waiting Now

Urgent Care - Lakeview

06 Patients
Waiting Now

Urgent Care - Merle Hay

00 Patients
Waiting Now

Urgent Care - Southglen

03 Patients
Waiting Now

Urgent Care - Urbandale

00 Patients
Waiting Now

Ovarian Cancer Screening Trial

Early detection of ovarian cancer greatly increases survival rates. This study will explore if the CA-125 level is an accurate detector of early stage ovarian cancer.

If you are a woman and want to considered for the trial here are the requirements:

- 50 to 75 years of age

- at least one year post-menopausal

- have at least one ovary

- are willing to have blood draw for a CA-125 test at least once a year

- are cancer free, or have been cancer/treatment free for at least 12 months

For more information about the Ovarian Cancer Screening Trial please contact the UnityPoint Health-Des Moines Office of Research at 515-241-6727.

FDA Approved Studies

The Office of Research has been involved with a variety of inpatient and outpatient studies since the office was established over 15 years ago. Many of the drugs and devices studied have received FDA approval. Following are a few of the FDA approved drugs/devices studied at UnityPoint Health:

Havrix™, dabigatran, alvimopan, micafungin, cinacalcet, omalizumab, dimethyl fumarate, telavancin, everolimus, methylnaltrexone, RotaTeq™, Endurant Endograft Stent™, Aimovig and the INCRAFT™ AAA Stent Graft System.

All studies help answer important clinical questions and help lead us down the path to improved healthcare for the patients we serve.